Username Password
S&P 500: 1,317.82 Change: +0.03%
danvee17
danvee17
P&P Score: 0.00
Stats
At least 5 active picks are required to calculate a P&P score.
About Me
Real name danvee17
Favorites
danvee17 has no favorites
Groups
danvee17 has no groups
Highlighted Picks
Most Recent  02/14/10
BUY    CYTX   $2.18
CYTORI THERAPEUTICS INC   -1.36%
Tissue regeneration technology, uses stemcells derived from patient's own body fat. Being used successfuly in Europe and testd in US now for breast r…more
Most Successful  02/14/10
BUY    CYTX   $2.18
CYTORI THERAPEUTICS INC   -92.99%
Tissue regeneration technology, uses stemcells derived from patient's own body f…more
Least Successful  02/14/10
BUY    CYTX   $2.18
CYTORI THERAPEUTICS INC   -92.99%
Tissue regeneration technology, uses stemcells derived from patient's own body f…more
Recent Posts
Most Recent Blog Post
danvee17 has no blog posts
Most Recent Comments

danvee17 has no recent comments

Picks

Open
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
02/14/2010 CYTX Rating: 1 BUY One to Three Years $7.38 $2.18
(-1.36%)
- -70.46% +22.53% -92.99 view
Closed
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
All
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
02/14/2010 CYTX Rating: 1 BUY One to Three Years $7.38 $2.18
(-1.36%)
- -70.46% +22.53% -92.99 view
Commentary
BUY: CYTORI THERAPEUTICS INC (CYTX) Rating: 1
Start Price: $7.38
Points: -92.99
Created: 02/14/2010
Tissue regeneration technology, uses stemcells derived from patient's own body fat. Being used successfuly in Europe and testd in US now for breast reconstruction. GE provides key technology used with the product. Being tested for heart muscle reconstruction. Videos avalilble at company website. Very large market potential.

Comments: 0 | Comment

Recs:
 
Sponsored Links